Janssen, PAJ; Jageneau, AHM; Demoen, PJA; van De. Westeringh, C; Raeymaekers, AHM; Wouters, MSJ; Sanczuk, S; Hermans, BKF; Loomans, JLM. Compounds related to pethidine--I. Mannich bases derived from norpethidine and acetophenones J. Med. Chem., 1 Feb 1959, 1 (1), 105–120. 695 kB. https://doi.org/10.1021/jm50002a008 #49 UV
Balayssac, S; Retailleau, E; Bertrand, G; Escot, M; Martino, R; Malet-Martino, M; Gilard, V. Characterization of heroin samples by 1H NMR and 2D DOSY 1H NMR Forensic Sci. Int., 1 Jan 2014, 234, 29-38. 1.4 MB. https://doi.org/10.1016/j.forsciint.2013.10.025 NMR
Chen, P; Braithwaite, RA; George, C; Hylands, PJ; Parkin, MC; Smith, NW; Kicman, AT. The poppy seed defense: a novel solution: ‘The poppy seed defense’ - a novel solution Drug Test. Anal., 1 Mar 2014, 6 (3), 194-201. 477 kB. https://doi.org/10.1002/dta.1590 MS
Wilkins, C; Sweetsur, P. The impact of the prohibition of benzylpiperazine (BZP) ‘legal highs’ on the prevalence of BZP, new legal highs and other drug use in New Zealand Drug Alcohol Depend., 1 Jan 2013, 127 (1-3), 72-80. 521 kB. https://doi.org/10.1016/j.drugalcdep.2012.06.014
Suryaprakash, N; Azoury, M; Goren, Z; Jelinek, R. Identification of heroin in street doses using 1D-TOCSY nuclear magnetic resonance J. Forensic Sci., 1 Sep 2000, 45 (5), 963–967. 535 kB. https://doi.org/10.1520/JFS14818J #Heroin NMR
Johnson, MW; Griffiths, RR; Hendricks, PS; Henningfield, JE. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act Neuropharmacology, 1 Nov 2018, 142, 143-166. 2.5 MB. https://doi.org/10.1016/j.neuropharm.2018.05.012 #Heroin
Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #11
Allen, AC; Cooper, DA; Moore, JM. 1H nuclear magnetic resonance of heroin’s D ring J. Forensic Sci., 1 Jul 1985, 30 (3), 908–914. 345 kB. https://doi.org/10.1520/JFS11025J #1 NMR
McKibben, T. Protecting group chemistry JCLIC, 1 Oct 1997, 7 (4), 30-42. 1.1 MB.
Lee, WLJ; Whei, AYT; Mangudi, M; Bian, CK. Heroin in Singapore — A review JCLIC, 1 Mar 2015, 25 (2), 18-24. 2.2 MB.
Antonides, LH; Brignall, RM; Costello, A; Ellison, J; Firth, SE; Gilbert, N; Groom, BJ; Hudson, SJ; Hulme, MC; Marron, J; Pullen, ZA; Robertson, TBR; Schofield, CJ; Williamson, DC; Kemsley, EK; Sutcliffe, OB; Mewis, RE. Rapid identification of novel psychoactive and other controlled substances using low-field 1H NMR spectroscopy ACS Omega, 30 Apr 2019, 4 (4), 7103–7112. 1.3 MB. https://doi.org/10.1021/acsomega.9b00302 #Heroin NMR
Cook, CE; Brine, DR. Pyrolysis products of heroin J. Forensic Sci., 1 Jan 1985, 30 (1), 251–261. 393 kB. https://doi.org/10.1520/JFS10990J #F MS,NMR,UV
Mella-Raipán, J; Romero-Parra, J; Recabarren-Gajardo, G. DARK classics in chemical neuroscience: Heroin and desomorphine ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3905–3927. 4.8 MB. https://doi.org/10.1021/acschemneuro.0c00262 #Heroin
Philp, M; Shimmon, R; Stojanovska, N; Tahtouh, M; Fu, S. Development and validation of a presumptive colour spot test method for the detection of piperazine analogues in seized illicit materials Anal. Methods, 1 Jan 2013, 5 (20), 5402. 783 kB. https://doi.org/10.1039/c3ay40511g #Heroin MS,NMR,IR,spot
Neville, GA. High-resolution proton magnetic resonance spectra of morphine and its three O-acetyl derivatives Magn. Reson. Chem., 1 Jan 1987, 25 (1), 31–35. 446 kB. https://doi.org/10.1002/mrc.1260250108 #DAM NMR,other
Azoury, M; Zelkowicz, A; Goren, Z; Almog, J. Evaluation of ninhydrin analogues and other electron-deficient compounds as spray reagents for drugs on thin layer chromatograms Microgram J., 1 Jan 2003, 1 (1–2), 23–31. 318 kB. spot
King, LA; Corkery, JM. An index of fatal toxicity for drugs of misuse Hum. Psychopharmacol. Clin. Exp., 1 Mar 2010, 25 (2), 162–166. 95 kB. https://doi.org/10.1002/hup.1090 #Heroin